相关实验视频

Updated: Jun 13, 2025

Real Time Detection of In Vitro Tumor Cell Apoptosis Induced by CD8+ T Cells to Study Immune Suppressive Functions of Tumor-infiltrating Myeloid Cells

Real Time Detection of In Vitro Tumor Cell Apoptosis Induced by CD8+ T Cells to Study Immune Suppressive Functions of Tumor-infiltrating Myeloid Cells

Published on: January 29, 2019

消除障碍:针对VISTA,扭转瘤微环境中的MDSC介导的T细胞抑制

Yayuan Deng¹, Mengjia Shi², Lin Yi¹

¹The First College of Clinical Medicine, Chongqing Medical University, Chongqing, China.

|September 17, 2024

概括

免疫检查点抑制剂 (ICI) 在癌症治疗中表现有前途,但耐药性很常见. 准V-域Ig抑制T细胞激活 (VISTA) 在髓状细胞衍生抑制细胞上可以克服这种抵抗.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
癌症研究癌症研究

背景情况:

免疫检查点抑制剂 (ICI) 已经改变了癌症治疗,但许多患者表现出耐药性.
骨髓原抑制细胞 (MDSCs) 创造了一个免疫抑制性瘤微环境 (TME),阻碍了免疫疗法的有效性.
维域Ig抑制T细胞激活 (VISTA) 是一种关键的免疫检查点蛋白,在MDSC表达.

研究的目的:

审查VISTA在TME中对MDSCs的监管中的作用.
探索VISTA作为克服ICI耐药性的潜在治疗点.

主要方法:

对调查VISTA在癌症免疫力中的作用的研究进行文献综述.
分析证据,将MDSC上的VISTA表达与免疫抑制和ICI耐药性联系起来.

主要成果:

维斯塔在MDSCs上高度表达,并有助于免疫抑制的TME.
准VISTA提出了一个潜在的战略,以加强对ICI的响应.

结论:

维斯塔在通过MDSCs调解免疫抑制方面发挥着重要作用.
调节VISTA可能是改善癌症免疫治疗结果的可行方法.

关键词:

国际投资机构 (ICI) 是国际投资机构 (ICI) 的一个组成部分.免疫疗法耐药性免疫疗法耐药性在MDSC中,MDSC是MDSC.瘤微环境是一个微环境.在视野中看到的.

更多相关视频

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses

Published on: May 6, 2019

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...